Cargando…
Effectiveness of Standard-Dose vs. Low-Dose Alteplase for Acute Ischemic Stroke Within 3–4.5 h
BACKGROUND: The efficacy and safety of intravenous alteplase administered 3–4.5 h after acute ischemic stroke have been demonstrated. However, whether responses differ between low-dose and standard-dose alteplase during this time window and whether certain subgroups benefit more remain unknown. PATI...
Autores principales: | Chen, Chih-Hao, Tang, Sung-Chun, Chen, Yu-Wei, Chen, Chih-Hung, Tsai, Li-Kai, Sung, Sheng-Feng, Lin, Huey-Juan, Huang, Hung-Yu, Po, Helen L., Sun, Yu, Chen, Po-Lin, Chan, Lung, Wei, Cheng-Yu, Lee, Jiunn-Tay, Hsieh, Cheng-Yang, Lin, Yung-Yang, Lien, Li-Ming, Jeng, Jiann-Shing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883875/ https://www.ncbi.nlm.nih.gov/pubmed/35237225 http://dx.doi.org/10.3389/fneur.2022.763963 |
Ejemplares similares
-
Intravenous Thrombolysis Administration 3–4.5 h After Acute Ischemic Stroke: A Retrospective, Multicenter Study
por: Chen, Yu-Wei, et al.
Publicado: (2019) -
Comparison of Different Dosages of Alteplase in Atrial Fibrillation–Related Acute Ischemic Stroke After Intravenous Thrombolysis: A Nationwide, Multicenter, Prospective Cohort Study in Taiwan
por: Lin, Sheng‐Feng, et al.
Publicado: (2022) -
Low Cholesterol Levels Increase Symptomatic Intracranial Hemorrhage Rates After Intravenous Thrombolysis: A Multicenter Cohort Validation Study
por: Lin, Sheng-Feng, et al.
Publicado: (2019) -
Combined Effects of MMP-7, MMP-8 and MMP-26 on the Risk of Ischemic Stroke
por: Hsieh, Fang-I, et al.
Publicado: (2019) -
Pre-treatment of Single and Double Antiplatelet and Anticoagulant With Intravenous Thrombolysis for Older Adults With Acute Ischemic Stroke: The TTT-AIS Experience
por: Lin, Sheng-Feng, et al.
Publicado: (2021)